P-291 Factors predictive for response to azacitidine treatment in MDS patients – A report by Polish Adult Leukemia Group

MLA

Małgorzata Wojciechowska, et al. “P-291 Factors Predictive for Response to Azacitidine Treatment in MDS Patients – A Report by Polish Adult Leukemia Group.” Leukemia Research, vol. 37, May 2013, pp. S153–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........552aee82215e2a3f9967bcc0b3aaa7a6&authtype=sso&custid=ns315887.

APA

Małgorzata Wojciechowska, Wanda Knopinska-Posluszny, M. Zalewska, Beata Stella-Holowiecka, Agnieszka Kopacz, A. Waszczuk-Gajda, J. Drozd-Sokolowska, A. Kolkowska-Lesniak, Andrzej Mital, Anna Szmigielska-Kapłon, Krzysztof Madry, & J. Dwilewicz-Trojaczek. (2013). P-291 Factors predictive for response to azacitidine treatment in MDS patients – A report by Polish Adult Leukemia Group. Leukemia Research, 37, S153–S154.

Chicago

Małgorzata Wojciechowska, Wanda Knopinska-Posluszny, M. Zalewska, Beata Stella-Holowiecka, Agnieszka Kopacz, A. Waszczuk-Gajda, J. Drozd-Sokolowska, et al. 2013. “P-291 Factors Predictive for Response to Azacitidine Treatment in MDS Patients – A Report by Polish Adult Leukemia Group.” Leukemia Research 37 (May): S153–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........552aee82215e2a3f9967bcc0b3aaa7a6&authtype=sso&custid=ns315887.